Voyageur Pharmaceuticals Ltd
- LAST PRICE0.0550
- TODAY'S CHANGE (%)0.0050 (10.0000%)
- Bid / Lots0.0500/ 88
- Ask / Lots0.0550/ 74
- Open / Previous Close0.0550 / 0.0500
- Day Range
- 52 Week Range
- Volume14,155
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VM |
|---|---|---|
| 09:32 ET | 14000 | 0.055 |
Apr 3, 2024
Voyageur Pharmaceuticals Ltd Grants Deferred Share Units Compensation to Independent Directors, from 9:02AM ET on Wednesday Apr 03, 2024 by Dow Jones
9:02AM ET on Wednesday Apr 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Voyageur Pharmaceuticals Ltd | 6.9M | -5.5x | --- |
MindBio Therapeutics Corp | 7.5M | -2.1x | --- |
Blueberries Medical Corp | 6.0M | -2.6x | --- |
Bhang Inc | 5.1M | -0.7x | --- |
Intellipharmaceutics International Inc | 2.6M | -0.6x | --- |
Mojave Brands Inc | 3.0M | -2.4x | --- |
Company Information
Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ingredients. The Company is focused on producing its own barium, iodine and fullerene minerals. The Company, through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc., is engaged in acquiring, exploring and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada and the state of Utah, United States. Its properties include Jubilee Mountain, Falcon and Paradox Basin. It owns a 100% interest in two barium sulphate (barite) projects, including the Frances Creek and Pedley Mountain property. It holds interests in a high-grade iodine, lithium, and bromine brine project situated in Utah, United States. It owns a 100% interest in two battery mineral projects that is focused on copper/zinc development. Its pipeline products include SmoothX 2.0%, MultiX Thick, MultiX Thin, HDX, LDX, VY-101 and VY-103.
Contact Information
- Headquarters
- Dome Tower 800, 333 7 Ave. S.W.CALGARY, AB, Canada T2P 2Z1
- Phone
- 403-923-5944
- Fax
- 403-508-2670
Executives
- President, Chief Executive Officer, Director
- Brent Willis
- Chief Financial Officer
- Albert Deslauriers
- Chief Operating Officer
- Bradly Willis
- Director
- Agustin Gago
- Independent Director
- Trent Abraham
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 138.9M |
Voyageur Pharmaceuticals Ltd does not pay a dividend. | |
Beta | 0.52 |
EPS | $-0.01 |
Book Value | $0.01 |
P/E Ratio | -5.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
